France-Isabelle Auzanneau received her BSc in Chemistry in 1985 and her Ph.D. in Organic Chemistry in 1989 under the supervision of Dr. Ladislas Szabó; both degrees were received from the Université de Paris XI (Paris-Sud, Orsay, France). Subsequent postdoctoral research appointments were with Dr. David R. Bundle at the National Research Council in Ottawa, Ontario, Canada (1989–1992), Dr. Morten Meldal at the Carlsberg Laboratory in Copenhagen, Denmark (1993), and Professor B. Mario Pinto at Simon Fraser University in Burnaby, British Columbia, Canada (1194-1995). In 1995, she took a position at the École Nationale Supérieure de Chimie de Clermont-Ferrant (France) as a Maître de Conférences. In June 1998, she joined the Pasteur-Merieux Connaught (now Sanofi Aventis) research laboratories in Toronto as a Research Scientist-Leader of the Carbohydrate Synthetic Facility and then Head of the Bioorganic Section. In June 2000, she joined the Department of Chemistry at the University of Guelph as Assistant Professor, was promoted to Associate Professor with tenure in 2005 and to Professor in 2013. Group research interests are focused in the areas of synthetic carbohydrate chemistry, immunochemistry and molecular modeling in particular as these fields relate to blood group antigens, anti-cancer vaccines and anti-bacterial vaccines. For several years, the group has carried out studies on the synthesis, conformation and immunochemistry of the Lex and Lea blood group antigens, more recently the group has prepared analogues and fragments of the dimeric Lex and the LeaLex Tumor Associated Carbohydrate Antigens (TACAs) to identify potential anti-cancer vaccine candidates based on these TACAs. Recognitions include the Premier’s Research Excellence Award awarded by the Government of Ontario (2003).
- NEWS & EVENTS
- CORE SERVICES